Education
About Us
Working with TipRanks
Follow Us
SpectraCure AB (SE:SPEC)
FRANKFURT:SPEC
SPEC Stock Chart & Stats
kr0.18
kr0.10(5.82%)
At close: 4:00 PM EST
kr0.18
kr0.10(5.82%)
Day’s Range― - ―
52-Week Rangekr0.14 - kr1.53
Previous CloseN/A
Volume60.95K
Average Volume (3M)1.15M
Market Cap
kr67.42M
Enterprise Valuekr61.46M
Total Cash (Recent Filing)kr25.51M
Total Debt (Recent Filing)kr3.40M
Price to Earnings (P/E)―
Beta-0.56
Next Earnings
Feb 19, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.09
Shares Outstanding401,334,320
10 Day Avg. Volume1,242,664
30 Day Avg. Volume1,152,681
Financial Highlights & Ratios
PEG Ratio-0.75
Price to Book (P/B)2.32
Price to Sales (P/S)0.00
P/FCF Ratio-6.68
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
SPEC FAQ
What was SpectraCure AB’s price range in the past 12 months?
SpectraCure AB lowest stock price was kr0.14 and its highest was kr1.53 in the past 12 months.
What is SpectraCure AB’s market cap?
SpectraCure AB’s market cap is kr67.42M.
When is SpectraCure AB’s upcoming earnings report date?
SpectraCure AB’s upcoming earnings report date is Feb 19, 2026 which is in 56 days.
How were SpectraCure AB’s earnings last quarter?
SpectraCure AB released its earnings results on Nov 13, 2025. The company reported -kr0.085 earnings per share for the quarter, missing the consensus estimate of N/A by -kr0.085.
Is SpectraCure AB overvalued?
According to Wall Street analysts SpectraCure AB’s price is currently Overvalued.
Does SpectraCure AB pay dividends?
SpectraCure AB does not currently pay dividends.
What is SpectraCure AB’s EPS estimate?
SpectraCure AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does SpectraCure AB have?
SpectraCure AB has 401,334,320 shares outstanding.
What happened to SpectraCure AB’s price movement after its last earnings report?
SpectraCure AB reported an EPS of -kr0.085 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -9.137%.
Which hedge fund is a major shareholder of SpectraCure AB?
Currently, no hedge funds are holding shares in SE:SPEC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
SpectraCure AB
SpectraCure AB (SPEC) is a medical technology company operating primarily in the field of cancer treatment. The company specializes in developing and commercializing innovative systems for photodynamic therapy (PDT), a minimally invasive treatment approach that uses light-sensitive drugs to target and destroy cancer cells. SpectraCure's core product is its proprietary interstitial PDT (IPDT) system, designed to treat solid tumors such as prostate cancer. The company is committed to advancing cancer care by providing effective and less invasive treatment options.
Technical Analysis
SciBase Holding AB
―
Luxbright AB
―
Scandinavian Real Heart AB
―
ScandiDos AB
―
Chordate Medical Holding AB
―